Clinical Trial

Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors

Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Experienced anesthesiologists often attempt to anticipate and blunt the hypertensive responses seen in varying degrees at critical moments of surgical stimulation. Additionally, it may take a long time to treat acute intraoperative hypertension using anesthetics, and there may be a subsequent period of hypotension due to over-compensation. Most practicing anesthesiologists rely on antihypertensive drugs for the rapid control of elevated arterial blood pressure, when volatile anesthetics and narcotics need to be discontinued for awakening. Relatively high doses of antihypertensive drugs, such as labetalol, nicardipine, or esmolol, are commonly used, regardless of the anesthetic technique.One of the main methods to control arterial blood pressure intraoperatively, was to use a typical antihypertensive regimen on an as-needed basis as well as common methods; adjustments in the concentration of volatile anesthetic.
Trial Details
NCT Number NCT07434206
Lead Sponsor South Egypt Cancer Institute
Conditions Thyroid Neoplasms
Enrollment 80 participants
Start Date 2024-04-25
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-25